← back to search

Peng Su

North China University of Science and Technology ·
Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Hippo pathway signaling and YAP/TAZ, Ubiquitin and proteasome pathways, Economic Sanctions and International Relations, and MicroRNA in disease regulation.
h-index
35
citations
3,861
works
139
NIH funding
primary concept
email

Recent publications

VCPIP1 facilitates pancreatic adenocarcinoma progression via Hippo/YAP signaling
Cell Death and Disease 2025cited by 4position: middledoi
[Analysis of risk factors of diaphragmatic hernia after thoraco-laparoscopic minimally invasive McKeown esophagectomy].
PubMed 2025cited by 0position: middledoi
Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1
Autophagy 2023cited by 91position: middledoi
OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer
Oncogene 2022cited by 68position: middledoi
YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis
Nature Communications 2022cited by 67position: middledoi
circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway
Molecular Therapy 2021cited by 198position: middledoi
KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer
Cancer Research 2020cited by 90position: middledoi
circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
Oncogene 2019cited by 163position: middledoi
Epigenetic Regulation of <i>NAMPT</i> by <i>NAMPT-AS</i> Drives Metastatic Progression in Triple-Negative Breast Cancer
Cancer Research 2019cited by 130position: middledoi
Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer
Molecular Therapy — Nucleic Acids 2019cited by 99position: middledoi
SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2
Cell Death and Differentiation 2018cited by 234position: middledoi
A magnetic nanomaterial modified with poly-lysine for efficient removal of anionic dyes from water
Chemical Engineering Journal 2014cited by 101position: middledoi
A dual function magnetic nanomaterial modified with lysine for removal of organic dyes from water solution
Chemical Engineering Journal 2013cited by 133position: middledoi
53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-κB through miR-146a
Carcinogenesis 2012cited by 47position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qifeng Yang · Qilu Hospital of Shandong University7 papers (2012–2023)Hanwen Zhang · Shihezi University6 papers (2018–2023)Ying Liu · Tangshan People's Hospital6 papers (2018–2023)Bing Chen · Guangzhou University of Chinese Medicine6 papers (2018–2023)Ning Zhang · Chinese University of Hong Kong5 papers (2018–2023)Yaming Li · Shanghai Medical College of Fudan University5 papers (2019–2023)Wenjing Zhao · Kunming University of Science and Technology5 papers (2018–2021)Xiaolong Wang · Shandong University4 papers (2018–2023)Xiaojin Song · University of Shanghai for Science and Technology4 papers (2019–2021)Yiran Liang · Fudan University4 papers (2019–2021)Yuting Sang · Shanghai Medical College of Fudan University3 papers (2019–2019)Lijuan Wang · Pingdingshan University3 papers (2018–2019)Renbo Guo · Shandong University2 papers (2019–2019)Lijuan Wang · Xuzhou Medical College2 papers (2019–2023)Xiaoyan Li · Shandong University2 papers (2019–2019)Yanru Zhang · Shandong University2 papers (2013–2014)Jiashu Zhang · Harbin Medical University2 papers (2018–2019)Bao-Xiang Zhao · Shandong University2 papers (2013–2014)Tingting Ma · China Pharmaceutical University2 papers (2019–2019)Dianwen Han · Shandong University2 papers (2019–2021)